Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
163,384,965
-
Total 13F shares
-
177,873,869
-
Share change
-
+22,989,320
-
Total reported value
-
$3,479,096,232
-
Put/Call ratio
-
221%
-
Price per share
-
$19.56
-
Number of holders
-
229
-
Value change
-
+$511,413,657
-
Number of buys
-
147
-
Number of sells
-
85
Institutional Holders of Dyne Therapeutics, Inc. - Common Stock (DYN) as of Q4 2025
As of 31 Dec 2025,
Dyne Therapeutics, Inc. - Common Stock (DYN) was held by
229 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
177,873,869 shares.
The largest 10 holders included
T. Rowe Price Investment Management, Inc., JANUS HENDERSON GROUP PLC, VANGUARD GROUP INC, BlackRock, Inc., Atlas Venture Life Science Advisors, LLC, STATE STREET CORP, FMR LLC, FCPM III SERVICES B.V., ADAGE CAPITAL PARTNERS GP, L.L.C., and Orbis Allan Gray Ltd.
This page lists
229
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.